319 related articles for article (PubMed ID: 20138413)
21. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
22. Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.
Smulders RA; Stehouwer CD; Schalkwijk CG; Donker AJ; van Hinsbergh VW; TeKoppele JM
Thromb Haemost; 1998 Jul; 80(1):52-7. PubMed ID: 9684785
[TBL] [Abstract][Full Text] [Related]
23. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
[TBL] [Abstract][Full Text] [Related]
25. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
DCCT/EDIC research group
Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
[TBL] [Abstract][Full Text] [Related]
26. High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G;
J Diabetes Complications; 2016; 30(4):693-9. PubMed ID: 26861948
[TBL] [Abstract][Full Text] [Related]
27. Urinary N-acetyl-beta-glucosaminidase activity in type I diabetes mellitus.
Jones AP; Lock S; Griffiths KD
Ann Clin Biochem; 1995 Jan; 32 ( Pt 1)():58-62. PubMed ID: 7762951
[TBL] [Abstract][Full Text] [Related]
28. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.
Kidney Int; 1995 Jun; 47(6):1703-20. PubMed ID: 7643540
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes.
Kordonouri O; Hartmann R; Müller C; Danne T; Weber B
Horm Res; 1998; 50 Suppl 1():23-7. PubMed ID: 9676993
[TBL] [Abstract][Full Text] [Related]
30. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
[TBL] [Abstract][Full Text] [Related]
31. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
32. Renal outcomes in patients with type 1 diabetes and macroalbuminuria.
de Boer IH; Afkarian M; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B;
J Am Soc Nephrol; 2014 Oct; 25(10):2342-50. PubMed ID: 24925722
[TBL] [Abstract][Full Text] [Related]
33. High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes.
Perkins BA; Rabbani N; Weston A; Adaikalakoteswari A; Lee JA; Lovblom LE; Cardinez N; Thornalley PJ
Sci Rep; 2020 Jul; 10(1):12709. PubMed ID: 32728119
[TBL] [Abstract][Full Text] [Related]
34. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS
Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264
[TBL] [Abstract][Full Text] [Related]
35. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
[TBL] [Abstract][Full Text] [Related]
36. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients.
Uslu S; Efe B; Alataş O; Kebapçi N; Colak O; Demirüstü C; Yörük A
J Nephrol; 2005; 18(5):559-67. PubMed ID: 16299682
[TBL] [Abstract][Full Text] [Related]
37. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
[TBL] [Abstract][Full Text] [Related]
38. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects.
Lopes-Virella MF; Baker NL; Hunt KJ; Cleary PA; Klein R; Virella G;
Diabetes Care; 2013 Aug; 36(8):2317-23. PubMed ID: 23514730
[TBL] [Abstract][Full Text] [Related]
39. Urinary N-acetyl-beta-D-glucosaminidase activity does not predict development of diabetic nephropathy.
Agardh CD; Tallroth G; Hultberg B
Diabetes Care; 1987; 10(5):604-6. PubMed ID: 3677979
[TBL] [Abstract][Full Text] [Related]
40. Effect of exercise on urinary N-acetyl-beta-D-glucosaminidase activity and albumin excretion in children with type I diabetes mellitus.
Brouhard BH; Allen K; Sapire D; Travis LB
Diabetes Care; 1985; 8(5):466-72. PubMed ID: 4053933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
